Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Peter Clark, MA, MD, FRCP: A Payer Perspective

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Mar
05
Today In Oncology
FDA Approves Teclistamab and Daratumumab For Relapsed or Refractory Multiple Myeloma
Medical Societies and More Respond to HHS RFI on AI Use in Clinical Care
Accuracy of Molecular Inference–Based AI Model for CNS Tumor Diagnosis
Activity Observed with Novel KRAS Inhibitor in Pancreatic Cancer
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo